Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    ADC Therapeutics SA

    NYSE: ADCT · Real-Time Price · USD
    3.46
    0.12 (3.59%)
    At close: Jun 05, 2025, 3:59 PM
    3.60
    4.05%
    Pre-market: Jun 06, 2025, 04:26 AM EDT

    ADC Therapeutics SA Statistics

    Share Statistics

    ADC Therapeutics SA has 99.18M shares outstanding. The number of shares has increased by 2.97% in one year.

    Shares Outstanding

    n/a
    		 99.18M

    Shares Change (YoY)

    n/a
    		 2.97%

    Shares Change (QoQ)

    n/a
    		 2.48%

    Owned by Institutions (%)

    n/a
    		 53.89%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 300

    FTD / Avg. Volume

    n/a
    		 0.06%

    Short Selling Information

    The latest short interest is 4.33M, so 4.36% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 4.33M

    Short % of Shares Out

    n/a
    		 4.36%

    Short % of Float

    n/a
    		 5.55%

    Short Ratio (days to cover)

    n/a
    		 9

    Valuation Ratios

    The PE ratio is -1.22 and the forward PE ratio is -2.43. ADC Therapeutics SA's PEG ratio is 0.03.

    PE Ratio

    n/a
    		 -1.22

    Forward PE

    n/a
    		 -2.43

    PS Ratio

    n/a
    		 2.79

    Forward PS

    n/a
    		 0.9

    PB Ratio

    n/a
    		 -0.95

    P/FCF Ratio

    n/a
    		 -1.55

    PEG Ratio

    n/a
    		 0.03
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for ADC Therapeutics SA.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 3.82, with a Debt / Equity ratio of -0.61.

    Current Ratio

    n/a
    		 3.82

    Quick Ratio

    n/a
    		 3.59

    Debt / Equity

    n/a
    		 -0.61

    Debt / EBITDA

    n/a
    		 -1.19

    Debt / FCF

    n/a
    		 -0.99

    Interest Coverage

    n/a
    		 -2.6

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $263,422.05

    Profits Per Employee

    n/a
    		 $-600,174.9

    Employee Count

    n/a
    		 263

    Asset Turnover

    n/a
    		 0.22

    Inventory Turnover

    n/a
    		 0.32

    Taxes

    Income Tax

    n/a
    		 166K

    Effective Tax Rate

    n/a
    		 -0.11%

    Stock Price Statistics

    The stock price has increased by -0.57% in the last 52 weeks. The beta is 1.96, so ADC Therapeutics SA's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.96

    52-Week Price Change

    n/a
    		 -0.57%

    50-Day Moving Average

    n/a
    		 1.72

    200-Day Moving Average

    n/a
    		 2.19

    Relative Strength Index (RSI)

    n/a
    		 76

    Average Volume (20 Days)

    n/a
    		 497,952

    Income Statement

    In the last 12 months, ADC Therapeutics SA had revenue of 69.28M and earned -157.85M in profits. Earnings per share was -1.62.

    Revenue

    n/a
    		 69.28M

    Gross Profit

    n/a
    		 63.33M

    Operating Income

    n/a
    		 -130.65M

    Net Income

    n/a
    		 -157.85M

    EBITDA

    n/a
    		 -103.71M

    EBIT

    n/a
    		 -105.92M

    Earnings Per Share (EPS)

    n/a
    		 -1.62
    Full Income Statement

    Balance Sheet

    The company has 250.87M in cash and 123M in debt, giving a net cash position of 127.87M.

    Cash & Cash Equivalents

    n/a
    		 250.87M

    Total Debt

    n/a
    		 123M

    Net Cash

    n/a
    		 127.87M

    Retained Earnings

    n/a
    		 -1.49B

    Total Assets

    n/a
    		 272.54M

    Working Capital

    n/a
    		 200.19M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -123.83M and capital expenditures -867K, giving a free cash flow of -124.7M.

    Operating Cash Flow

    n/a
    		 -123.83M

    Capital Expenditures

    n/a
    		 -867K

    Free Cash Flow

    n/a
    		 -124.7M

    FCF Per Share

    n/a
    		 -1.28
    Full Cash Flow Statement

    Margins

    Gross margin is 91.41%, with operating and profit margins of -188.59% and -227.84%.

    Gross Margin

    n/a
    		 91.41%

    Operating Margin

    n/a
    		 -188.59%

    Pretax Margin

    n/a
    		 -225.37%

    Profit Margin

    n/a
    		 -227.84%

    EBITDA Margin

    n/a
    		 -149.7%

    EBIT Margin

    n/a
    		 -188.59%

    FCF Margin

    n/a
    		 -180%

    Dividends & Yields

    ADCT does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for ADCT is $8, which is 131.2% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $8

    Price Target Difference

    n/a
    		 131.2%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 5
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -7.65

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist